Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05258630 · ClinicalTrials.gov registry record · Phase 2
Diabetes Homeless Medication Support
A Phase 2 study of Diabetes Mellitus, Type 2 and Psychological Distress, sponsored by Hennepin Healthcare Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT05258630 is a Phase 2 study of Diabetes Mellitus, Type 2 and Psychological Distress that has completed, run by Hennepin Healthcare Research Institute. The registered enrollment target is 38 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05258630, a Phase 2 study of Diabetes Mellitus, Type 2 and Psychological Distress, has completed, sponsored by Hennepin Healthcare Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized pilot trial of the Diabetes Homeless Medication Support intervention vs. brief diabetes education will test the perception and feasibility of anticipated study procedures and refine randomization and blinding.
Conditions Studied
Interventions
- BEHAVIORAL Enhanced usual care
- BEHAVIORAL Diabetes Homeless Medication Support (D-Homes)
Study Locations (1)
Minnesota
- Hennepin Healthcare - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2022-02-23 |
| Est. Completion | 2023-07-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05258630
The ClinicalTrials.gov registry entry for NCT05258630 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The listed sponsor is Hennepin Healthcare Research Institute, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which Enhanced usual care is the first listed.
NCT05258630 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05258630 about?
NCT05258630 is a clinical study titled "Diabetes Homeless Medication Support". This randomized pilot trial of the Diabetes Homeless Medication Support intervention vs. brief diabetes education will test the perception and feasibility of anticipated study procedures and refine randomization and blinding.
What is the current status of trial NCT05258630?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 38 participants. The study started on 2022-02-23. Estimated completion is 2023-07-12.
What conditions does trial NCT05258630 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Psychological Distress, Housing Problems.
What interventions are being tested in trial NCT05258630?
The interventions under investigation include: Enhanced usual care (BEHAVIORAL), Diabetes Homeless Medication Support (D-Homes) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05258630?
This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05258630 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DETERMINE: Detemir vs NPH
RECRUITING · Phase 2
-
MANAGe-DM: Novel Nurse Case Management to Improve Diabetes Outcomes in Formerly Incarcerated Black Men
RECRUITING · Phase 2
-
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
RECRUITING · Phase 2
-
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin
RECRUITING · Phase 2
-
A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy
ACTIVE NOT RECRUITING · Phase 2
-
Addressing Basic Needs to Improve Diabetes Outcomes in Medicaid Beneficiaries
ACTIVE NOT RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.